Clinical Experience with Abemaciclib in Patients Previously Treated with Another CDK 4/6 Inhibitor in a Tertiary Hospital: A Case Series Study

SIMPLE SUMMARY: This research aimed to study the effectiveness and safety of a drug called abemaciclib in patients with metastatic breast cancer (MBC) who had previously received similar treatments. The medical records of 11 patients who were given abemaciclib after their disease worsened despite pr...

Descripción completa

Detalles Bibliográficos
Autores principales: de Luna Aguilar, Alicia Milagros, Fuentes, Javier David Benitez, Ortega Anselmi, Justo, Olalla Inoa, Jennifer, Flores Navarro, Paloma, Lopez de Sá, Alfonso, Fuentes Antras, Jesus, Rodríguez Rey, Cristina, Ortega Candil, Aída, Moreno Antón, Fernando, García Sáenz, Jose Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526325/
https://www.ncbi.nlm.nih.gov/pubmed/37760421
http://dx.doi.org/10.3390/cancers15184452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526325/
https://www.ncbi.nlm.nih.gov/pubmed/37760421
http://dx.doi.org/10.3390/cancers15184452

Ejemplares similares